A rapid flow cytometric method to explore cellular immunity against Toxoplasma gondii in humans

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 6, 1998, Pages 745-748

  Kahi, Sandrine ^a,b   Cozon, Grégoire J N ^a,b,c   Greenland, Timothy ^c   Wallon, Martine ^a,b   Gay Andrieu, Françoise ^a,b   Peyron, François ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; T LYMPHOCYTE ACTIVATION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0031770599     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.6.745-748.1998     Document Type: Article

References (16)

1. Anderson, S. E., J. L. Krahenbuhl, and J. S. Remington. 1979. Longitudinal studies of lymphocyte responses to Toxoplasma antigens in humans infected with T. gondii. J. Clin. Lab. Immunol. 2:293-297.
2. Canessa, A., V. Pistoia, A. Merli, G. Melioli, A. Terragna, and M. Ferranini. 1988. An in vitro model of toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites. J. Immunol. 140:3580-3588.
3. Caruso, A., S. Licenziati, M. Corulli, A. D. Canaris, M. A. De Francesco, S. Fiorentini, L. Peroni, F. Fallacara, F. Dima, A. Balsari, and A. Turano. 1997. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 27:71-76.
4. Cebrian, M., E. Yagüe, M. Rincon, M. Lopez-Botet, M. O. de Landazuri, and F. Sanchez-Madrid. 1988. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168:1621-1637.
5. Corradin, G., H. M. Etlinger, and J. M. Chiller. 1977. Lymphocyte specific T-cell dependent proliferative response with lymph node cells from primed mice. J. Immunol. 119:1048-1053.
6. Darcy, F., and F. Santoro. 1994. Toxoplasmosis, p. 163-201. In F. Kierszenbaum (ed.), Parasitic infections and the immune system. Academic Press Inc., San Diego, Calif.
7. Denkers, E. Y., P. Caspar, and A. Sher. 1994. Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor Vβ5-bearing CD8+ lymphocytes. J. Exp. Med. 180:985-994.
8. Johnson, W. D., Jr. 1981. Chronological development of cellular immunity in human toxoplasmosis. Infect. Immun. 33:948-949.
9. Luft, B. J., and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211-219.
10. MacLeod, R., M. O. Beem, and R. G. Estes. 1985. Lymphocyte anergy specific to Toxoplasma gondii antigens in a baby with congenital toxoplasmosis. J. Clin. Lab. Immunol. 17:149-153.
11. Maino, V. C., M. A. Suni, and J. J. Ruitenberg. 1995. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 20:127-133.
12. Mardiney, M., III, M. R. Brown, and T. A. Fleisher. 1996. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen-or antigen-induced proliferative capacity in normals. Cytometry 26:305-310.
13. Purner, M. B., R. L. Berens, P. B. Nash, A. van Linden, E. Ross, C. Kruse, E. C. Krug, and T. J. Curiel. 1996. CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans. Infect. Immun. 64:4330-4338.
14. Purner, M. B., E. C. Krug, P. Nash, D. R. Cook, R. L. Berens, and T. J. Curiel. 1995. Cross-reactivity of human Toxoplasma-specific T cells: implications for development of a potential immunotherapeutic or vaccine. J. Infect. Dis. 171:984-991.
15. Stray-Pedersen, B. 1980. Infants potentially at risk for congenital toxoplasmosis. Am. J. Dis. Child. 134:638-642.
16. Wilson, C. B., G. Desmonts, J. Couvreur, and J. S. Remington. 1983. Lymphocyte transformation in the diagnosis of congenital toxoplasma infection. N. Engl. J. Med. 302:785-788.